Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/25/2009 | EP1618106B1 Carbacephem beta-lactam antibiotics |
11/25/2009 | CN101589060A Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
11/25/2009 | CN101588820A Alpha-lactalbumin composition |
11/25/2009 | CN101586143A Modulating production of pneumococcal capsular polysaccharide |
11/25/2009 | CN101586120A Rabies virus Flury-LEP vaccine strain reverse genetic operating system and LEP green fluorescent protein recombination viral vector |
11/25/2009 | CN101586115A Gene coexpression recombinant plasmid and DNA vaccine prepared from same |
11/25/2009 | CN101585854A New acyclic nucleoside phosphonate compound as well as composition, preparation method and application thereof |
11/25/2009 | CN101585847A Synthetic method of faropenem sodium |
11/25/2009 | CN101585846A Preparation method of faropenem sodium |
11/25/2009 | CN101585843A Process for preparing rifaximin |
11/25/2009 | CN101585836A Novel method for preparing Nevirapine |
11/25/2009 | CN101585820A 1,2,3-selenadiazole thioacetanilides derivatives, preparation method thereof and application thereof |
11/25/2009 | CN101584866A Polyethylene glycol modified human interleukin-2, preparation method and application thereof |
11/25/2009 | CN101584863A Medicament for external use for treating onychomycosis |
11/25/2009 | CN101584861A Methods for enhancing innate and adaptive immunity and antigen immunogenicity |
11/25/2009 | CN101584836A Detoxifying Chinese medicament and preparation method thereof |
11/25/2009 | CN101584827A Traditional Chinese medicine for treating cold in children |
11/25/2009 | CN101584826A Medicament for comprehensively treating a plurality of skin diseases |
11/25/2009 | CN101584818A Traditional Chinese medicine for treating urinary tract infection |
11/25/2009 | CN101584806A Pure traditional Chinese medicine composition for treating avian influenza, preparing method and application thereof |
11/25/2009 | CN101584775A Rehabilitation soup for restraining liver virus |
11/25/2009 | CN101584773A Chinese herbal medicament for treating skin diseases |
11/25/2009 | CN101584751A Antifungal pharmaceutical composition |
11/25/2009 | CN101584747A Antibacterial antivirus Chinese medicinal composition for animal |
11/25/2009 | CN101584745A Preparation for new antivirus Chinese medicine formulation for animal |
11/25/2009 | CN101584735A Pharmaceutical composition for preventing and treating chicken bursal disease and nephrotic bronchitis and preparation method thereof |
11/25/2009 | CN101584734A Medicinal composition for treating hepatitis B and preparation method thereof |
11/25/2009 | CN101584715A Spray for preventing and treating skin damnification and resisting infection |
11/25/2009 | CN101584711A Nano-silver antibacterial washing fluid |
11/25/2009 | CN101584703A Pharmaceutical composition for treating colpitis and preparation method thereof |
11/25/2009 | CN101584702A Method of preparing extract of Mallotus apelta and uses for fighting hepatitis B virus |
11/25/2009 | CN101584701A Antiviral composition |
11/25/2009 | CN101584694A Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method |
11/25/2009 | CN101584679A Novel oral capsule preparation for treating cancer and AIDS |
11/25/2009 | CN101584676A Matrine sustained release preparation and preparing method thereof |
11/25/2009 | CN101584671A Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium |
11/25/2009 | CN101584665A Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof |
11/25/2009 | CN101584664A Cefodizime sodium proliposome preparation and preparation method thereof |
11/25/2009 | CN101584658A Preparation method of amikacin sulfate injection |
11/25/2009 | CN101584657A Tilmicosin solution and preparation method thereof |
11/25/2009 | CN101584656A Novel use of amikacin sulfate injection |
11/25/2009 | CN100562342C Oligonucleotide drug for preventing and treating influenza virus infection |
11/25/2009 | CN100562334C Medicinal composition for treating phthisis |
11/25/2009 | CN100562328C Chinese medicinal composition for treating cold |
11/24/2009 | US7622582 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one |
11/24/2009 | US7622494 Chemical compounds |
11/24/2009 | US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
11/24/2009 | US7622487 Piperidine derivative, process for producing the same, and use |
11/24/2009 | US7622481 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
11/24/2009 | US7622469 2,4-diamino-1,3,5-triazine derivatives |
11/24/2009 | US7622457 Polynucleotides encoding anticoagulant fusion proteins |
11/24/2009 | US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
11/24/2009 | US7622124 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
11/24/2009 | US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
11/24/2009 | CA2475712C Nicotinamide derivatives useful as pde4 inhibitors |
11/24/2009 | CA2433197C Gyrase inhibitors and uses thereof |
11/24/2009 | CA2423384C New cross-linked derivatives of hyaluronic acid |
11/24/2009 | CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
11/24/2009 | CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability |
11/24/2009 | CA2362153C Antimicrobial/endotoxin neutralizing polypeptide |
11/24/2009 | CA2360039C Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
11/24/2009 | CA2343113C Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
11/24/2009 | CA2341566C Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
11/24/2009 | CA2201105C Inhibitor of stem cell proliferation and uses thereof |
11/24/2009 | CA2141574C Herpesvirus vaccines |
11/22/2009 | CA2666450A1 Novel strain of the genus lactobacillus and topical pharmaceutical formulations containing it |
11/19/2009 | WO2009140676A2 Compositions and methods for inhibition of retroviruses |
11/19/2009 | WO2009140500A1 Hepatitis c virus inhibitors |
11/19/2009 | WO2009140475A1 Hepatitis c virus inhibitors |
11/19/2009 | WO2009140287A1 Salinosporamide derivatives as proteasome inhibitors |
11/19/2009 | WO2009140236A2 Staphylococcus aureus-specific antibody preparations |
11/19/2009 | WO2009140215A2 Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds |
11/19/2009 | WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity |
11/19/2009 | WO2009139886A2 Targeting an hiv-1 nef-host cell kinase complex |
11/19/2009 | WO2009139870A1 Oxo-imidazolyl compounds having antibacterial activity |
11/19/2009 | WO2009139792A1 Hcv protease inhibitors |
11/19/2009 | WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
11/19/2009 | WO2009139181A1 10a-azalide compound having 4-membered ring structure |
11/19/2009 | WO2009139004A2 Tat dna sequences, gene constructs, vaccine and processes thereof |
11/19/2009 | WO2009138860A1 Plant extract and its therapeutic use |
11/19/2009 | WO2009138799A1 Therapeutic uses of 1-cycl0pr0pyl-3 - [3- ( 5 -morpholin- 4 -ylmethyl- 1h-benz0imidaz0l- 2 -yl) -lh-pyrazol-4-yl] -urea |
11/19/2009 | WO2009138519A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME |
11/19/2009 | WO2009138494A2 Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors |
11/19/2009 | WO2009137916A1 Processes and intermediates for the preparation of oseltamivir and analogs thereof |
11/19/2009 | WO2009137881A1 Angiogenin-enriched milk fractions |
11/19/2009 | WO2009100723A3 Crystalline forms of an antibiotic substance |
11/19/2009 | WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition |
11/19/2009 | WO2009077586A3 Methods and compositions for the preparation and use of toxin conjugates |
11/19/2009 | WO2009065947A3 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids |
11/19/2009 | WO2009046220A3 Lipopeptides for delivery of nucleic acids |
11/19/2009 | WO2009010877A3 Conjugate purification |
11/19/2009 | US20090286958 Interferon-beta fusion proteins and uses |
11/19/2009 | US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few |
11/19/2009 | US20090286855 Interleukin-18 mutants, their production and use |
11/19/2009 | US20090286843 Macrocyclic compounds as inhibitors of viral replication |
11/19/2009 | US20090286841 Certain chemical entities, compositions, and methods |
11/19/2009 | US20090286814 Hcv protease inhibitors |
11/19/2009 | US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
11/19/2009 | US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders |
11/19/2009 | US20090286757 Antiviral composition |